Indication
For the prevention of ototoxicity caused by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.
Medicine details
- Medicine name:
- sodium thiosulfate (Pedmarqsi)
- SMC ID:
- SMC2730
- Pharmaceutical company
- Norgine Ltd
- BNF chapter
- Ear, nose and oropharynx
- Submission type
- Full
- Publication due date:
- TBC
- SMC meeting date:
- TBC
- Patient group submission deadline:
- 03 February 2025